COVID-19 studies for: C19 studies:  HC QHC Q IvermectinIVM Vitamin DVitamin D ZincZn REGN-COV2REGN LY-CoVLY RemdesivirRMD
HC Q study #160
Source   PDF   Share   Tweet
See all 181 studies
10/30
Positive
Late treatment study
Tehrani et al., International Journal of Infectious Diseases, doi:10.1016/j.ijid.2020.10.071 (Peer Reviewed)
Risk factors for mortality in adult COVID-19 patients; frailty predicts fatal outcome in older patients
Retrospective 255 hospitalized patients, 65 treated with HC Q, showing unadjusted RR 0.87, p=0.63. Confounding by indication is likely.
death, ↓13.4%, p=0.63
Source   PDF   Share   Tweet
See all 181 studies
Please send us corrections, updates, or comments.
Submit